Tropism of AAV.CPP.16 in the respiratory tract and its application for a CRISPR-based gene therapy against SARS-CoV-2
Z. Yang, Y. Yao, X. Chen, V. Madigan, X. Fan, J. Pu, F. Bei
This study evaluates AAV.CPP.16 as a gene delivery vector for respiratory diseases and demonstrates its use in a CRISPR-based therapy targeting SARS-CoV-2.
bioRxiv · Nov 17, 2023 · PreprintBioengineering